Long-term dobutamine in heart failure.

نویسندگان

  • M Gorrie
  • A Nicholls
چکیده

This patient has cranial diabetes insipidus and hypoparathyroidism with low serum testosterone level and normal range FSH and LH. There was no evidence of granulomatous diseases, histiocytosis or sarcoidosis despite a history ofpolyuria for more than 10 years, although these may take years to manifest2 and diabetes insipidus may be an early manifestation. However, as has been reported,' about 30% of these patients have antibodies against vasopressin-secreting cells in the hypothalamus. The hypocalcaemia and hyperphosphataemia with serum parathyroid hormone levels (mid-molecule RIA), inappropriately low for the level of calcium, indicate hypoparathyroidism which again on clinical grounds appears to be sporadic and idiopathic, and for which the most likely cause is autoimmune. He also had normal secondary sexual features with borderline low serum testosterone which could indicate the later development of hypogonadotrophic hypogonadism in which usually there is a hypothalamic defect in gonadotrophin releasing hormone release3 and is not commonly associated with disorders of other hypothalamic hormone secretion4 including diabetes insipidus.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Long-term intermittent dobutamine infusion, combined with oral amiodarone for end-stage heart failure: a randomized double-blind study.

STUDY OBJECTIVES To examine the effects of long-term intermittent dobutamine infusion, combined with oral amiodarone in patients with congestive heart failure (CHF) refractory to standard medical treatment. DESIGN Prospective, randomized, double-blind, placebo-controlled clinical trial. SETTING Inpatient and outpatient heart failure clinic in a university teaching hospital. PATIENTS AND I...

متن کامل

THERAPY AND PREVENTION CONGESTIVE HEART FAILURE Sustained-improvement of cardiac function in patients with congestive heart failure after short- term infusion of dobutamine

Fifteen patients with congestive cardiomyopathy (six idiopathic and nine alcoholic) manifested by heart failure (New York Heart Association class III or IV) were randomly assigned to a protocol in which dobutamine (n = 8) or 5% dextrose in water (n = 7) was infused continuously for 72 hr. The dose of dobutamine was titrated to increase cardiac output to twice the baseline values. The patients w...

متن کامل

The Role of Calcium-Sensitizer Levosimendan for the Treatment of Heart Failure

In the treatment of heart failure, clinical signs are low cardiac output, therapy with positive inotropic agents in an acute cardiac care is mandatory. Three classes of inotropic drugs are currently used, including betaadrenergic agonists (especially dobutamine), phosphodiesterase inhibitors (such as milrinone) and the recently developed calcium sensitizers such as levosimendan. The classic ino...

متن کامل

Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial.

CONTEXT Because acute decompensated heart failure causes substantial morbidity and mortality, there is a need for agents that at least improve hemodynamics and relieve symptoms without adversely affecting survival. OBJECTIVE To assess the effect of a short-term intravenous infusion of levosimendan or dobutamine on long-term survival. DESIGN, SETTING, AND PATIENTS The Survival of Patients Wi...

متن کامل

Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes.

The appropriate role of intravenous inodilator therapy (inotropic agents with vasodilator properties) in the management of acute heart failure syndromes (AHFS) has long been a subject of controversy, mainly because of the lack of prospective, placebo-controlled trials and a lack of alternative therapies. The use of intravenous inodilator infusions, however, remains common, but highly variable. ...

متن کامل

Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography.

OBJECTIVES This study was designed to address, in patients with severe ischemic left ventricular dysfunction, whether dobutamine stress echocardiography (DSE) can predict improvement of left ventricular ejection fraction (LVEF), functional status and long-term prognosis after revascularization. BACKGROUND Dobutamine stress echocardiography can predict improvement of wall motion after revascul...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Postgraduate medical journal

دوره 70 825  شماره 

صفحات  -

تاریخ انتشار 1994